StonvexLoading…
StonvexStonvexStonvexCore line items from NVVE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $4.79M | $2.84M | $1.25M | $934.30K |
Operating Income | $-32.18M | $-25.50M | $-20.38M | $-5.59M |
Net Income | $-30.82M | $-24.76M | $-20.25M | $-6.87M |
EPS (Diluted) | $-75.65 | $-2.76 | $-4.97 | $-3.88 |
Total Assets | $17.39M | $16.76M | $16.99M | $16.48M |
Total Liabilities | $14.86M | $18.67M | $19.82M | $19.72M |
Cash & Equivalents | $5.47M | $939.41K | $1.77M | $1.19M |
Free Cash Flow OCF − CapEx | $-16.68M | $-12.41M | $-7.33M | $-1.82M |
Shares Outstanding | 2.07M | 22.48M | 10.92M | 3.12M |